The female reproductive system is a hormone-driven set of organs—ovaries, fallopian tubes, uterus, cervix, and vagina—that produces eggs, cycles the uterine lining, and supports pregnancy. Its core engine is the hypothalamic-pituitary-ovarian axis, a feedback loop in which the brain and ovaries continuously adjust each other's output. This explainer covers the signaling mechanics, the numbers behind a typical cycle, common edge cases, persistent misconceptions, and the thresholds that should prompt medical evaluation.

The feedback loop that runs the cycle

The system is not a one-way command chain from brain to ovary. It is a closed loop with two feedback directions, and the direction flips midway through the cycle. Understanding that flip explains most of what happens month to month.

The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses rather than a steady stream. Pulse frequency matters: faster pulses bias the pituitary toward luteinizing hormone (LH), slower pulses toward follicle-stimulating hormone (FSH). The pituitary reads that rhythm and secretes LH and FSH into the blood. FSH recruits a cohort of ovarian follicles, each containing an egg and a shell of hormone-producing cells.

As follicles grow, they secrete estradiol. Early in the cycle, estradiol feeds back negatively—it tells the hypothalamus and pituitary to ease off FSH, so only the most sensitive follicle survives. This is why typically just one egg ovulates per cycle: the winner suppresses its competitors through hormone output, not through a separate selection organ.

Mid-cycle, the same estradiol switches sign. Sustained high levels trigger positive feedback: a sharp LH surge that ruptures the dominant follicle and releases the egg about 24 to 36 hours later. After ovulation, the ruptured follicle becomes the corpus luteum and secretes progesterone, which thickens and stabilizes the uterine lining. If no pregnancy occurs, the corpus luteum breaks down, progesterone falls, and the lining sheds. Falling progesterone also releases the brake on FSH, restarting the loop.

Quantified context: what a typical cycle looks like

A reference cycle runs 28 days, though population data show wide normal variation—cycles from roughly 21 to 35 days are generally considered regular in adults. Menstrual bleeding typically lasts up to about 7 days, with average blood loss around 30 to 50 milliliters; loss above 80 milliliters is the conventional definition of heavy menstrual bleeding.

Cycle phase Typical timing (28-day reference) Dominant hormone What happens
Menstruation Days 1–5 Low estradiol, low progesterone Lining sheds; FSH begins to rise
Follicular phase Days 1–13 Rising estradiol Follicle cohort grows; one dominant follicle selected
Ovulation Around day 14 LH surge Egg released; fertile window peaks
Luteal phase Days 15–28 Progesterone Lining stabilizes; corpus luteum active
Luteal-follicular transition Final days Progesterone withdrawal Corpus luteum regresses; cycle restarts

The luteal phase is the more constant half, usually 12 to 14 days. Variation in cycle length therefore comes mostly from the follicular phase—a fact that matters when interpreting cycle-tracking data. The fertile window spans roughly the 5 days before ovulation plus ovulation day, because sperm survive in cervical mucus for several days while the egg remains viable for only about 12 to 24 hours.

Ovarian reserve declines with age in a predictable arc. Roughly 1 to 2 million oocytes are present at birth, several hundred thousand remain at puberty, and the decline accelerates in the late 30s. This is a population pattern, not a personal prediction; individual trajectories vary widely.

Edge cases: when the loop misbehaves

Polycystic ovary syndrome (PCOS) is the most common ovulatory disorder. Its signature is elevated androgen levels and disordered GnRH pulsing, which biases LH over FSH. Follicles start to grow but stall, and ovulation becomes irregular or absent. The ovaries may appear polycystic on ultrasound, but imaging alone does not define the condition.

Hypothalamic amenorrhea sits at the opposite extreme. Severe energy deficit—from restrictive eating, excessive exercise, or major stress—suppresses GnRH pulsatility. The result is low FSH and LH, low estradiol, and absent periods. It is a functional shutdown, not ovarian failure, which is why restoring energy balance can restart the cycle.

Primary ovarian insufficiency (POI) is true ovarian failure before age 40, with loss of follicles and rising FSH. It differs fundamentally from hypothalamic amenorrhea: in POI the ovary cannot respond, while in hypothalamic amenorrhea the ovary is capable but understimulated.

Endometriosis involves endometrial-like tissue outside the uterus. The tissue responds to cycle hormones, bleeds locally, and drives inflammation and pain. Symptoms often do not correlate with lesion burden—a small amount of disease can cause severe pain, and extensive disease can be nearly silent.

Timeline: what happens after ovulation

Timepoint (relative to LH surge) Event
Hour 0 LH surge begins
~24–36 hours Follicle ruptures; egg released
~12–24 hours post-release Egg viability window closes
Days 7–10 post-ovulation Corpus luteum at peak progesterone output
~Day 14 post-ovulation Corpus luteum regresses if no pregnancy
Days 1–4 after regression Menstruation begins

The counterintuitive detail: the LH surge precedes ovulation by a day or more, so urinary LH tests detect the surge, not the egg release itself. A positive test means ovulation is likely within roughly the next one to two days, not that it has already happened.

Misconceptions worth correcting

A 28-day cycle is a textbook average, not a rule. Normal cycles range widely, and short-term variation of several days is common.

Ovulation does not reliably occur on day 14. In a 28-day reference cycle it clusters near mid-cycle, but in longer cycles it shifts later because the follicular phase lengthens.

You can get pregnant outside the "fertile window" you calculated. Sperm survival and cycle irregularity create uncertainty, and cycle-tracking apps estimate rather than measure.

Douching is not hygienic maintenance. The vagina maintains its own acidic environment through Lactobacillus; disrupting it can increase infection risk. Professional guidance generally advises against it.

Menopause is a transition, not a single event. It is defined retrospectively after 12 consecutive months without bleeding, and the years before it involve variable hormone fluctuations and irregular cycles.

Practical actions and evaluation thresholds

Track cycle length, bleeding duration, and pain pattern for at least three cycles before drawing conclusions. Patterns matter more than single data points.

Seek evaluation for any of the following red flags:

Bleeding that soaks through a pad or tampon hourly for more than a couple of hours, or bleeding lasting beyond 7 days Pelvic pain severe enough to disrupt daily function, especially pain that worsens with periods No period by age 15, or no period for 3 months in someone who previously cycled regularly Bleeding after menopause, which always warrants assessment New severe pain with fever, which can signal infection

For contraception and fertility planning, method choice depends on goals and health history; guidance from a clinician or a public health body such as the CDC is more reliable than general articles. Treat cycle-app predictions as estimates.

Limitations and what this explainer cannot tell you

This piece describes stable physiology, not individual diagnosis. Hormone values, cycle timing, and thresholds vary by age, weight, medication use, and health conditions. Specific numeric cutoffs for conditions like PCOS or POI come from clinical guidelines and require laboratory context—they are not self-diagnosis tools.

Evidence for some interventions, particularly supplements marketed for cycle regulation, is limited or mixed. Claims about "balancing hormones" through lifestyle alone should be treated cautiously.

The system described here is the healthy reference model. Real cycles, real symptoms, and real fertility outcomes require individualized assessment, and any decision about testing or treatment belongs with a qualified clinician.